Evidence map›Paper›PMID 32341660›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2020

Effect of

Mahdieh Safarzad, Abdoljalal Marjani, Marie Saghaeian Jazi, Durdi Qujeq, Seyed Mostafa Mir, Majid Marjani, Abbas Nezhadebrahimi Kaldehi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mahdieh SafarzadMetabolic Disorders Research Center, Department of Biochemistry and Biophysics, Gorgan Faculty of Medicine, Golestan University Medical Sciences, Gorgan, Iran.
Abdoljalal MarjaniMetabolic Disorders Research Center, Department of Biochemistry and Biophysics, Gorgan Faculty of Medicine, Golestan University Medical Sciences, Gorgan, Iran.
Marie Saghaeian JaziMetabolic Disorders Research Center, Department of Biochemistry and Biophysics, Gorgan Faculty of Medicine, Golestan University Medical Sciences, Gorgan, Iran.
Durdi QujeqCellular and Molecular Biology Research Center, Health Research Institute, Department of Clinical Biochemistry, Student Research Committee, Babol University of Medical Science, Babol, Iran.ORCID 0000-0003-1344-9344
Seyed Mostafa MirCellular and Molecular Biology Research Center, Health Research Institute, Department of Clinical Biochemistry, Student Research Committee, Babol University of Medical Science, Babol, Iran.
Majid MarjaniFaculty of Pharmacy, Eastern Mediterranean University, Famagusta 99628, Turkey.
Abbas Nezhadebrahimi KaldehiMetabolic Disorders Research Center, Department of Biochemistry and Biophysics, Gorgan Faculty of Medicine, Golestan University Medical Sciences, Gorgan, Iran.
Golestan University · IRBabol University of Medical Sciences · IREastern Mediterranean University · CY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aim of this study was to assess the effects of MATERIALS AND

methods

resultsOur findings showed that

conclusionThe

Indexed as

C2C12cell linesCRI-D2glucose metabolismHepG2Rubus anatolicus

Identifiers

PMID32341660
PMCPMC7166088
OpenAlexW3015431545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.